Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $124.36 million. The enterprise value is $123.62 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TELO has 29.61 million shares outstanding. The number of shares has increased by 6.65% in one year.
| Current Share Class | 29.61M |
| Shares Outstanding | 29.61M |
| Shares Change (YoY) | +6.65% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.98% |
| Owned by Institutions (%) | 6.92% |
| Float | 17.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 281.33 |
| P/TBV Ratio | 281.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.74 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.04 |
Financial Efficiency
Return on equity (ROE) is -1,752.69% and return on invested capital (ROIC) is -243.60%.
| Return on Equity (ROE) | -1,752.69% |
| Return on Assets (ROA) | -204.69% |
| Return on Capital (ROIC) | -243.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.55M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.09 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.38 |
| Average Volume (20 Days) | 75,310 |
Short Selling Information
The latest short interest is 546,346, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 546,346 |
| Short Previous Month | 576,960 |
| Short % of Shares Out | 1.85% |
| Short % of Float | 3.13% |
| Short Ratio (days to cover) | 1.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.42M |
| Pretax Income | n/a |
| Net Income | -22.96M |
| EBITDA | n/a |
| EBIT | -10.42M |
| Earnings Per Share (EPS) | -$0.79 |
Full Income StatementBalance Sheet
The company has $834,638 in cash and $93,432 in debt, giving a net cash position of $741,206 or $0.03 per share.
| Cash & Cash Equivalents | 834,638 |
| Total Debt | 93,432 |
| Net Cash | 741,206 |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 442,074 |
| Book Value Per Share | 0.01 |
| Working Capital | 442,074 |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.55M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.55M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |